Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 930

Similar articles for PubMed (Select 16086620)

1.

An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder.

Iosifescu DV, Nierenberg AA, Mischoulon D, Perlis RH, Papakostas GI, Ryan JL, Alpert JE, Fava M.

J Clin Psychiatry. 2005 Aug;66(8):1038-42.

PMID:
16086620
3.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
5.

Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder.

Papakostas GI, Petersen TJ, Nierenberg AA, Murakami JL, Alpert JE, Rosenbaum JF, Fava M.

J Clin Psychiatry. 2004 Feb;65(2):217-21.

PMID:
15003076
7.

Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression.

Alpert JE, Mischoulon D, Rubenstein GE, Bottonari K, Nierenberg AA, Fava M.

Ann Clin Psychiatry. 2002 Mar;14(1):33-8.

PMID:
12046638
8.

T3 augmentation of SSRI resistant depression.

Abraham G, Milev R, Stuart Lawson J.

J Affect Disord. 2006 Apr;91(2-3):211-5. Epub 2006 Feb 17.

PMID:
16483669
11.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
12.

Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial.

Perry EB, Berman RM, Sanacora G, Anand A, Lynch-Colonese K, Charney DS.

J Clin Psychiatry. 2004 Feb;65(2):238-43.

PMID:
15003079
13.

Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.

Cooper-Kazaz R, Apter JT, Cohen R, Karagichev L, Muhammed-Moussa S, Grupper D, Drori T, Newman ME, Sackeim HA, Glaser B, Lerer B.

Arch Gen Psychiatry. 2007 Jun;64(6):679-88.

PMID:
17548749
15.

Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.

Elliott AJ, Russo J, Bergam K, Claypoole K, Uldall KK, Roy-Byrne PP.

J Clin Psychiatry. 1999 Apr;60(4):226-31.

PMID:
10221282
16.

Sertraline as monotherapy in the treatment of psychotic and nonpsychotic depression.

Simpson GM, El Sheshai A, Rady A, Kingsbury SJ, Fayek M.

J Clin Psychiatry. 2003 Aug;64(8):959-65.

PMID:
12927014
17.

An open-label study of adjunctive modafinil in patients with sedation related to serotonergic antidepressant therapy.

Schwartz TL, Azhar N, Cole K, Hopkins G, Nihalani N, Simionescu M, Husain J, Jones N.

J Clin Psychiatry. 2004 Sep;65(9):1223-7.

PMID:
15367049
18.
19.

Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.

Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG.

J Clin Psychiatry. 2006 May;67(5):736-46.

PMID:
16841623
20.

[Management strategies for major depressive episodes as a function of initial response to an SSRI or SNRI antidepressant: results of the ORACLE survey].

Spadone C, Sylvestre M, Chiarelli P, Richard-Berthe C.

Encephale. 2005 Nov-Dec;31(6 Pt 1):698-704. French.

PMID:
16462689
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk